Treatment of AIDS Related Non-Hodgkin's Lymphoma with Combination Mitoguazone Dihydrochloride and Low Dose Chop Chemotherapy: Results of a Phase II study

Author： Tulpule Anil   Espina Byron M.   Pedro Santabarbara A. B.   Palmer Maria   Schiflett Joanne   Boswell William   Smith Susan   Levine Alexandra M.  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.22, Iss.1, 2004-01, pp. : 63-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dose-intensified CHOP ± etoposide in non-Hodgkin's lymphoma

By  

Inpharma, Vol. 1, Iss. 1455, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Rituximab added to CHOP chemotherapy shows promise as a treatment for HIV-associated non-Hodgkin's lymphoma (NHL)

By  

Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

An Evaluation of the Cost-Effectiveness of Rituximab in Combination with Chemotherapy for the First-Line Treatment of Follicular Non-Hodgkin's Lymphoma in the UK

By Ray Joshua A.   Carr Emma   Lewis Gavin   Marcus Robert  

Value in Health, Vol. 13, Iss. 4, 2010-06 ,pp. : 346-357

Blackwell Publishing

Access to resources Recommend Favorite

Cost Effectiveness of High-Dose Chemotherapy with Autologous Stem Cell Support as Initial Treatment of Aggressive Non-Hodgkin's Lymphoma

By Fagnoni Philippe   Milpied Noel  

PharmacoEconomics, Vol. 27, Iss. 1, 2009-01 ,pp. : 55-68

Adis International

Access to resources Recommend Favorite

Ibritumomab tiuxetan Y-90 plus high-dose BEAM chemotherapy was well tolerated in older patients with non-Hodgkin's lymphoma

By  

Inpharma, Vol. 1, Iss. 1617, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite